Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 91.7% in August

Posted by George Bondi on Sep 10th, 2026

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC – Get Free Report) was the target of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 1,207 shares, a decrease of 91.7% from the August 15th total of 14,573 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 33,162 shares, the short-interest ratio is presently 0.0 days.

Cardiac Biotech Solutions Stock Performance

CBSC remained flat at $0.04 on Thursday. 30,000 shares of the company were exchanged, compared to its average volume of 13,347. Cardiac Biotech Solutions has a 52-week low of $0.02 and a 52-week high of $0.06. The business has a fifty day moving average price of $0.03 and a two-hundred day moving average price of $0.04.

Cardiac Biotech Solutions Company Profile

(Get Free Report)

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 91.7% in August

Cardiac Biotech Solutions Stock Performance

Cardiac Biotech Solutions Company Profile

Further Reading

You might be interested in: